EPAS1 and neoplasm: Furthermore, based on the expression profile data, the Tumor Immune Dysfunction and Exclusion (TIDE) algorithm was used to predict the relationship between HIF‐2α expression and RCC patient response to immune checkpoint inhibitors (ICIs).